COPD Information Center
Distinct differences occur between eosinophilic COPD and COPD patients with asthma.
Increased residual volume is associated with a larger pulmonary artery in patients with COPD.
The use of inhaled corticosteroids is associated with an increased risk of pneumonia in asthma patients.
Use of the empowerment approach is necessary for health promotion in older patients with COPD, but little attention has been paid to the dimensions of empowerment in COPD management.
Utibron Neohaler inhalation powder is indicated for the long-term maintenance treatment of airflow obstruction in patients with COPD.
The European Respiratory Society and the American Thoracic Society have released a guideline for the treatment of patients with COPD exacerbations.
A daily dose of atorvastatin could reduce pulmonary artery pressure among patients with COPD.
A novel technique involving NPPV reduced the risks of nosocomial infection, requirement for intubation, and hospital mortality in patients with COPD.
Researchers also observed no difference in 30-day mortality rates between patients in the ICU and those who received regular inpatient care in another hospital unit.
Countries committed to introducing policies such as high tobacco taxes and smoke-free public spaces.